Why has the Oxford-AstraZeneca vaccine faced so much scrutiny?

European safety concerns over vaccine remain despite positive data from UK campaign

Boris Johnson poses with a vial of the Oxford-AstraZeneca vaccine
Boris Johnson poses with a vial of the Oxford-AstraZeneca vaccine
(Image credit: Paul Ellis/WPA Pool/Getty Images)

Even the most ardent supporter of the government would struggle to deny that the UK’s pandemic response has had its fair share of low points. But in one regard the country has streaked ahead of its neighbours: vaccinations.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

 Sorcha Bradley is a writer at The Week and a regular on “The Week Unwrapped” podcast. She worked at The Week magazine for a year and a half before taking up her current role with the digital team, where she mostly covers UK current affairs and politics. Before joining The Week, Sorcha worked at slow-news start-up Tortoise Media. She has also written for Sky News, The Sunday Times, the London Evening Standard and Grazia magazine, among other publications. She has a master’s in newspaper journalism from City, University of London, where she specialised in political journalism.